It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Quoin Pharmaceuticals (NASDAQ: QNRX) Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
April 2, 2025 Comments Off on Quoin Pharmaceuticals (NASDAQ: QNRX) Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric PatientContinued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus [...] -
April 2, 2025 Comments Off on Innovation Beverage Group (NASDAQ: IBG) Expands U.S. Distribution of its Award-Winning Bitters Through One of the Nation’s Largest Beverage Alcohol Distributors
-
March 25, 2025 Comments Off on Predictive Oncology (NASDAQ: POAI) Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
-
March 25, 2025 Comments Off on Tenon Medical (NASDAQ:TNON) Announces FDA Clearance of Catamaran(R) SI Joint Fusion System for New Indication to Augment Spinal Fusion
-
March 24, 2025 Comments Off on Damon Inc. (NASDAQ: DMN) Announces Closing of Upsized $16.5 Million Underwritten Public Offering
Popular Articles
-
Quoin Pharmaceuticals (NASDAQ: QNRX) Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric Patient
April 2, 2025 Comments Off on Quoin Pharmaceuticals (NASDAQ: QNRX) Announces Additional Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study and Approval to Initiate Testing of a Second Pediatric PatientContinued Clear Visual Evidence of Almost Completely Healed Skin After 6 weeks Treatment High Durability of Treatment Effect of QRX003 with Continuous Daily Dosing Patient Continues Not to Require Previously Necessary Medications With Patient’s Pruritus [...] -
February 9, 2009 Comments Off on Post 2
-
February 9, 2009 Comments Off on Palm(NASDAQ: PALM) builds momentum;
-
February 9, 2009 Comments Off on Post 4
-
February 10, 2009 Comments Off on Value Investing Opportunities (Prospect List Here)